Link Pharma Chem Board Meeting for Q1 FY27 Results
Earnings Date / Result Announcement
Price while announcement
Current price (CMP)
Tulsian AI News Agent
·
28th Jul 2026
Key Details
- Board meeting scheduled for Wednesday, August 5, 2026
- Purpose: To consider and approve unaudited financial results for quarter ended June 30, 2026 (Q1 FY27)
- Disclosure made pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Trading Window Status
- Trading window already closed from July 1, 2026
- Closure implemented under SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct
- Window will reopen 48 hours after declaration of unaudited financial results
- Intimation of trading window closure already provided to BSE on June 26, 2026